Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Long-term Objective A

yellow dot 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Projects Found: 10
Total Funding: 4139740
Project Title Funding Funding Institution

Project Title

Evaluation of a melanocortin agonist to improve social cognition in autism
$0

Funding

0

Institution

University of Sydney

Project Title

Randomized controlled trial of oxytocin treatment for social deficits in children with autism
$0

Funding

0

Institution

Stanford University

Project Title

Treatment of Overweight Induced by Antipsychotic Medication in Young People with ASD
$273,544

Funding

273544

Institution

Holland Bloorview Kids Rehabilitation Hospital

Project Title

Controlled trial of sertraline in young children with Fragile X Syndrome
$0

Funding

0

Institution

University of California, Davis

Project Title

A Controlled Trial of Sertraline in Young Children with ASD
$300,000

Funding

300000

Institution

University of California, Davis

Project Title

Augmenting language interventions for ASD: A translational approach
$274,364

Funding

274364

Institution

University of California, Los Angeles

Project Title

Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,562,872

Funding

2562872

Institution

University of North Carolina

Project Title

Neural Effects of Sustained Oxytocin Treatment in Children with Autism
$243,424

Funding

243424

Institution

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Project Title

The role of vasopressin in the social deficits of autism
$196,250

Funding

196250

Institution

Stanford University

Project Title

Piloting Treatment with Insulin-Like Growth Factor-1 in Phelan-McDermid Syndrome
$289,286

Funding

289286

Institution

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

 
Back to Top